InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by HEDRICK MARC H, Chairman & CEO. Officer active across 1 companies, notably Plus Therapeutics, INC.. In total, 7 reports have been logged. Total volume traded: €23k. The latest transaction was disclosed on 15 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€3,0995,000 shares@ €0.61970.0086% mcap13.3% of flow
Common Stock
SEC:0001209191-22-037240:0·
Ideal exit: 12 Mar 2023 (T+270)
€1,6072,500 shares@ €0.64270.0045% mcap6.9% of flow
Common Stock
SEC:0001209191-22-025901:0·
Ideal exit: 21 Jan 2023 (T+270)
€3,2415,000 shares@ €0.64830.0090% mcap13.9% of flow
Common Stock
SEC:0001209191-22-025718:0·
Ideal exit: 21 Jan 2023 (T+270)
€3,5782,500 shares@ €1.431246.6% of flow
Common Stock
SEC:0001209191-21-061724·
Ideal exit: 23 Jul 2022 (T+270)
€3,5782,500 shares@ €1.43120.0099% mcap15.4% of flow
Common Stock
SEC:0001209191-21-061724:0·
Ideal exit: 23 Jul 2022 (T+270)
€4,0982,183 shares@ €1.877453.4% of flow
Common Stock
SEC:0001209191-21-029409·
Ideal exit: 25 Jan 2022 (T+270)
€4,0982,183 shares@ €1.87740.011% mcap17.6% of flow
Common Stock
SEC:0001209191-21-029409:0·
Ideal exit: 25 Jan 2022 (T+270)
7 of 7 declarations
About HEDRICK MARC H
Marc H. Hedrick is the Chief Executive Officer of Plus Therapeutics, Inc. He leads the company by overseeing all operations and developing strategies for growth. His role is crucial for ensuring the success of the organization and meeting stakeholder needs.
